The industry lobby group AdvaMed says the commission tasked with advising Congress on new payment policy to combat the opioid crisis has neglected consideration of medical devices as a solution. AdvaMed is asking the Medicare Payment Advisory Commission to recommend Congress mandate a revision and review of prices for non-opioid treatments such as medical devices in a report to lawmakers in March.
At a Jan. 18 meeting of the commission in Washington DC, DeChane Dorsey, VP for payment and health-care delivery...